Ramantamig Trispecific Antibody in Multiple Myeloma: High Response Rates & Mild CRS | IMS 2026

Ramantamig Trispecific Antibody in Multiple Myeloma: High Response Rates & Mild CRS | IMS 2026
(Guest Lecture): October 2022 - Finding a Treasure Chest of Assets You Already Own
(Guest Lecture) September 2022 - Improved Fitness = More Options
(Guest Lecture): September 2022 - Diagnosis: A Never-Ending Story
Diagnosis: A Never-Ending Story - Jens Hillengass, MD, PhD | Round Table Buffalo, NY Sept 17, 2022
Moderated Discussion and Round Table Audience Q&A One | Round Table Buffalo, NY Sept 17, 2022
Improved Fitness = More Options - Jens Hillengass, MD, PhD | Round Table Buffalo, NY Sept 17, 2022
Round Table Audience Q&A Two | Round Table Buffalo, NY Sept 17, 2022
If a patient is being observed, what does observation look like?